{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1573105975601816192.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"NAID","@value":"10030874673"}}],"dc:title":[{"@language":"en","@value":"Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1583105975601816192","@type":"Researcher","foaf:name":[{"@language":"en","@value":"FURUTA T"}]}],"publication":{"prism:publicationName":[{"@language":"en","@value":"Br J Clin Pharmacol"}],"prism:publicationDate":"2010","prism:volume":"70","prism:startingPage":"383","prism:endingPage":"392"},"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282680081053568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of Cytochrome P450 2C19 Polymorphism on Target Lesion Outcome After Drug-Eluting Stent Implantation in Japanese Patients Receiving Clopidogrel"}]}],"dataSourceIdentifier":[{"@type":"CIA","@value":"10030874673"}]}